Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents (Q39881200)

15 September 2017

Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents (English)

1 reference

PubMed ID

1416856

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1416856

24 September 2022

1

Odds FC

1 reference

PMCID

192038

15 September 2017

language of work or name

English

0 references

publication date

1 August 1992

1 reference

15 September 2017

11

1 reference

full work available at URL

inferred from page(s)

https://europepmc.org/articles/PMC192038

1 reference

PubMed ID

1416856

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1416856

https://europepmc.org/articles/PMC192038?pdf=render

24 September 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

PubMed ID

1416856

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1416856

Antimicrobial Agents and Chemotherapy

24 September 2022

published in

1 reference

15 September 2017

36

1 reference

15 September 2017

8

1 reference

15 September 2017

1727-1737

1 reference

Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

In vitro studies with R 51,211 (itraconazole)

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

In vitro antifungal susceptibility testing and measurement of levels of antifungal agents in body fluids.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

In vitro activity of terbinafine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Testing of organisms for susceptibility to triazoles: is it justified?

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

In vitro and in vivo evaluation of antifungal agents

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Collaborative investigation of variables in susceptibility testing of yeasts

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeasts

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Comparison of vaginal flora after treatment with a clotrimazole 500 mg vaginal pessary or a fluconazole 150 mg capsule for vaginal candidosis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Quantitative microculture system with standardized inocula for strain typing, susceptibility testing, and other physiologic measurements with Candida albicans and other yeasts

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Tablet sensitivity testing on pathogenic fungi

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Azole resistance in Candida albicans.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

In vitro activity of fluconazole, a novel bistriazole antifungal agent

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia, and typhlitis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Fluconazole and Candida krusei fungemia.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Emergence of Candida krusei infections after therapy of oropharyngeal candidiasis with fluconazole.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

[Laboratory's controls of antifungal treatment by the fluconazole of the candidiasis in immunocompromised patients]

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Itraconazole vs amphotericin B: in vitro comparative evaluation of the minimal inhibitory concentration (MIC) against clinically isolated yeasts

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192038

Relative inhibition factors--a novel approach to the assessment of antifungal antibiotics in vitro

2 December 2018

1 reference

12 December 2020

Correlation of in Vitro Susceptibility Test Results with in Vivo Response: Flucytosine Therapy in a Systemic Candidiasis Model

1 reference

12 December 2020

In vitro potency and in vivo activity of azoles

1 reference

12 December 2020

Fluconazole resistance in Candida glabrata

1 reference

12 December 2020

Failure of fluconazole therapy in Candida krusei fungemia

1 reference

12 December 2020

Fluconazole in the treatment of oropharyngeal candidosis in HIV-positive patients

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.36.8.1727

1 reference

release_lpfcpxzknnbh3fqtggwkdwcqia

15 September 2017

0 references

PMCID

192038

1 reference

15 September 2017

1 reference

PMCID

192038